id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S5925 R15068 |
Artama (Carbamazepine) (Controls exposed to Lamotrigine, sick), 2013 | Caesarean section | during pregnancy (anytime or not specified) | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: No |
0.94 [0.62;1.43] C excluded (control group) |
191/1,084 32/173 | 223 | 1,084 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5909 R14883 |
Artama (Carbamazepine) (Controls unexposed, disease free), 2013 | Caesarean section | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes |
1.16 [0.99;1.36] excluded (control group) |
191/1,084 114,791/721,948 | 114,982 | 1,084 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5917 R14979 |
Artama (Carbamazepine) (Controls unexposed, sick), 2013 | Caesarean section | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: Yes | 0.95 [0.78;1.17] | 191/1,084 331/1,800 | 522 | 1,084 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6262 R16736 |
Borthen (Carbamazepine) (Controls exposed to Lamotrigine, sick), 2010 | Caesarean | during pregnancy (anytime or not specified) | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: No |
1.13 [0.75;1.71] C excluded (control group) |
81/388 44/233 | 125 | 388 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6259 R16712 |
Borthen (Carbamazepine) (Controls unexposed, disease free), 2010 | Caesarean | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes |
1.50 [1.20;1.90] excluded (control group) |
81/388 51,806/362,302 | 51,887 | 388 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6264 R16752 |
Borthen (Carbamazepine) (Controls unexposed, sick), 2010 | Caesarean | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: No | 1.19 [0.91;1.57] C | 81/388 337/1,863 | 418 | 388 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8220 R25721 |
Endo (Carbamazepine) (Controls unexposed, disease free), 2004 | Cesarean section | throughout pregnancy | retrospective cohort | unexposed, disease free excluded | Adjustment: No |
7.86 [1.93;32.11] C excluded (control group) |
4/8 74/656 | 78 | 8 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8223 R25766 |
Endo (Carbamazepine) (Controls unexposed, sick), 2004 | Cesarean section | throughout pregnancy | retrospective cohort | unexposed, sick | Adjustment: No | 1.29 [0.02;82.50] C | 4/8 0/1 | 4 | 8 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 3 studies | 1.03 [0.88;1.21] | 944 | 1,480 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Carbamazepine) (Controls unexposed, sick; 2: Carbamazepine) (Controls unexposed, sick; 3: Carbamazepine) (Controls unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 8220, 6262, 6259, 5925, 5909